Xvivo Perfusion AB (publ) (XVIPF) Financials

XVIPF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 26.7 million 3.5 million
March 31, 2026 257.9 million 31.3 million
Dec. 31, 2025 257.2 million 28.2 million
Sept. 30, 2025 250.7 million 29.9 million

XVIPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 5.7 million ?
Dec. 31, 2025 9.4 million ?
Sept. 30, 2025 ? ?

XVIPF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 1.7 million
March 31, 2026 3.8 million
Dec. 31, 2025 3.4 million
Sept. 30, 2025 457591

XVIPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.2 million 1.2 million -
March 31, 2026 32.2 million - 11.6 million
Dec. 31, 2025 31.6 million 12.3 million 12.3 million
Sept. 30, 2025 29.5 million 12.1 million 12.1 million

XVIPF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.2 million
March 31, 2026 3.3 million
Dec. 31, 2025 3.4 million
Sept. 30, 2025 3.4 million

XVIPF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 6.5 million 2.8 million 10.3 million -
March 31, 2026 1.1 million 3.8 million 10.7 million 7.7 million
Dec. 31, 2025 9.4 million 2.7 million 10.2 million 8.1 million
Sept. 30, 2025 2.1 million 2.5 million 8.8 million -

XVIPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 24.4 million 9.0 million
March 31, 2026 25.2 million 7.3 million
Dec. 31, 2025 24.5 million 8.6 million
Sept. 30, 2025 19.9 million 6.7 million

XVIPF

Price: $30.95

52 week price:
16.98
30.95

Earnings Per Share: 0.29 USD

P/E Ratio: 89.90

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 771.7 million

Links: